Adma Biologics reported $-13015000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Adma Biologics ADMA:US $ -13.02M 1.24M
Agile Therapeutics AGRX:US $ -15.22M 0.88M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
China Cord Blood CO:US 172.82M 4.37M
Kindred Biosciences KIN:US $ -7.33M 0.63M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Novavax NVAX:US $ -302.88M 40.54M
Omeros OMER:US $ -17936000 5.72M
Takeda 4502:JP Y 238074M 153426M